Company news
CABIO Biotech (Wuhan) Co. Ltd. news in 2026
CABIO Biotech (Wuhan) Co. Ltd.'s news releases, calls and decks from 2026, newest first.
(688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Progress of Litigation
November 4, 2026
(688089)"Cabio Biotech (Wuhan) Co., Ltd."Report for Q3 2026
October 29, 2026
(688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Provision for Credit and Asset Impairment for the First Three Quarters of 2026
October 29, 2026
(688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Progress of the Imposition of Other Risk Warning on the Company's Shares
October 29, 2026
(688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Resignation of the Securities Affairs Representative
October 16, 2026
(688089)"Cabio Biotech (Wuhan) Co., Ltd."Announcement on Progress of the Imposition of Other Risk Warning on the Company's Shares
September 29, 2026
Announcement on Receipt of the Notice of Response to Retrial and Progress of Litigation
September 14, 2026
Announcement on Progress of the Imposition of Other Risk Warning on the Company's Shares
August 28, 2026
Semi-annual Report for 2026
August 21, 2026
Announcement on Resignation of Independent Director
August 12, 2026
Announcement on Implementation of Cancellation of Repurchased Shares and Share Changes
August 3, 2026
Announcement on Imposition of Other Risk Warnings and Trading Suspension
July 24, 2026
Announcement on Notifying Creditors Regarding the Cancellation of Repurchased Shares
June 17, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
June 15, 2026
Announcement on Voluntary Disclosure of the Approval of Lacto-N-neotetraose
June 8, 2026
Notice on Convening the 2025 Annual General Meeting
May 24, 2026
Announcement on Participating in the SSE STAR Market's 2025 Annual Biological Products Industry Collective Performance Briefing and the Q1 2026 Performance Briefing
May 5, 2026
Special Report on Deposit and Actual Use of Raised Funds in 2025
April 22, 2026
Announcement on Resignation of Directors
March 25, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Implementation Result of Phase II Shares Repurchase and Share Changes
January 26, 2026
Announcement on Progress in Repurchasing Shares through Call Auction in Phase II
January 5, 2026